Sep 13, 2024, 15:50
Justin shares his success with a novel treatment for non-Hodgkin lymphoma – NCI Center for Cancer Research
NCI Center for Cancer Research shared the following post on LinkedIn:
“Justin joined a CCR trial in 2020 and benefited from a novel 5-drug treatment called ViPOR for non-Hodgkin lymphoma. His doctor describes him as likely cancer-free.
‘I wouldn’t be here without NCI,’ Justin effused. ‘The NIH Clinical Center is one of the country’s best-kept secrets.’
Read his full story.”
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 14, 2024, 16:54
Oct 14, 2024, 16:53
Oct 14, 2024, 16:51
Oct 14, 2024, 16:46
Oct 14, 2024, 16:28
Oct 14, 2024, 16:25